Medicis to Present at Piper Jaffray Health Care Conference
November 23 2011 - 8:00AM
Medicis (NYSE:MRX) today announced that the Company is scheduled to
present at the 23rd Annual Piper Jaffray Health Care Conference in
New York. A live webcast of its presentation scheduled for Tuesday,
November 29, 2011, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific
Time), may be accessed via the Internet.
The webcast will be available via a link on the Medicis
corporate website at http://www.Medicis.com/company/index.asp. This
link will allow visitors to the website to access the Medicis
presentation. An archive of the webcast will be available on
the Medicis corporate website for 10 business days following the
live presentation.
About Medicis
Medicis is the leading independent specialty pharmaceutical
company in the United States focusing primarily on the treatment of
dermatological and aesthetic conditions. The Company is
dedicated to helping patients attain a healthy and youthful
appearance and self-image. Medicis has leading branded
prescription products in a number of therapeutic and aesthetic
categories. The Company's products have earned wide acceptance
by both physicians and patients due to their clinical
effectiveness, high quality and cosmetic elegance.
The Company's products include the brands DYSPORT®
(abobotulinumtoxinA) 300 Units for Injection, PERLANE® Injectable
Gel, PERLANE-L® Injectable Gel with 0.3% Lidocaine, RESTYLANE®
Injectable Gel, RESTYLANE-L® Injectable Gel with 0.3% Lidocaine,
LOPROX® (ciclopirox) Gel 0.77% and Shampoo 1%, SOLODYN®
(minocycline HCl, USP) Extended Release Tablets, VANOS®
(fluocinonide) Cream, 0.1%, ZIANA® (clindamycin phosphate 1.2% and
tretinoin 0.025%) Gel, AMMONUL® (sodium phenylacetate and sodium
benzoate) Injection 10%/10%, BUPHENYL® (sodium phenylbutyrate)
Tablets and Powder and the over-the-counter brand ESOTERICA®.
For more information about Medicis, please visit the Company's
website at www.Medicis.com. Printed copies of the Company's
complete audited financial statements are available free of charge
upon request.
Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the Private Securities Litigation Reform
Act. All statements included in this press release that
address activities, events or developments that Medicis expects,
believes or anticipates will or may occur in the future are
forward-looking statements. These statements are based on
certain assumptions made by Medicis based on its experience and
perception of historical trends, current conditions, expected
future developments and other factors it believes are appropriate
in the circumstances. No assurances can be given, however,
that these activities, events or developments will occur or that
such results will be achieved. Such statements are subject to a
number of assumptions, risks and uncertainties, many of which are
beyond the control of Medicis. Several of these risks are outlined
in the Company's most recent annual report on Form 10-K for the
year ended December 31, 2010, and other documents we file with the
Securities and Exchange Commission. Forward-looking statements
represent the judgment of Medicis management as of the date of this
release, and Medicis disclaims any intent or obligation to update
any forward-looking statements contained herein, which speak as of
the date hereof.
NOTE: Full prescribing information for any Medicis prescription
product is available by contacting the Company or by visiting
www.Medicis.com. All trademarks are the property of their
respective owners.
CONTACT: Kara Stancell (media)
(480) 291-5454
Sean Andrews (investors)
(480) 291-5854
Medicis (NYSE:MRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medicis (NYSE:MRX)
Historical Stock Chart
From Sep 2023 to Sep 2024